Cite
APA Citation
Sloan, A. E., Fung, H., Reese, J., Rogers, L. R., Murphay, C., Lazrus, H., Dropulic, B., & Gerson, S. L. (n.d.). 141 Phase I Trial of Genetically Modified Hematopoietic Progenitor Cells Facilitate Bone Marrow Chemoprotection and Enabling TMZ/O6BG Dose Escalation Resulting in Improved Survival. Neurosurgery, 63, 157. http://access.bl.uk/ark:/81055/vdc_100128171503.0x000041